6 unknown. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 2 | Unknown 2 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism Paricalcitol, Placebo - Secondary Hyperparathyroidism | Phase 3 | Unknown | Chengdu Suncadia Medicine Co., Ltd. | 84 | 2022-02-01 | 2022-02-10 |
| Comparison of Total Parathyroidectomy With and Without Autotransplantation total PTX without autotransplantation, total PTX with autotransplantation - Secondary Hyperparathyroidism | Phase 3 | Unknown | The Second Hospital of Anhui Medical University | 96 | 2015-09-01 | 2015-08-31 |
| Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. omega-3 PUFAs, Standard care, placebo - 22q11 Deletion Syndrome | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 80 | 2014-06-01 | 2014-02-25 |
| ADD-ON Study to Existing Hypoparathyroidism Studies PTH1-84 in parent study - Hypoparathyroidism | Phase 3 | Unknown | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 62 | 2010-09-01 | 2018-02-28 |
| Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD) Cinacalcet HCl - Secondary Hyperparathyroidism | Phase 2 / Phase 3 | Unknown | ENRICO VERRINA | 30 | 2010-03-01 | 2011-11-24 |
| Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients Cholecalciferol, Placebo - Kidney Transplantation, Vitamin D Deficiency | Phase 3 | Unknown | Medical University of Vienna | 200 | 2009-05-01 | 2014-01-22 |
Hyperparathyroidism, Secondary (3) · 22q11 Deletion Syndrome (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Hypoparathyroidism (1) · Psychotic Disorders (1) · Recurrence (1) · Renal Insufficiency, Chronic (1) · Vitamin D Deficiency (1)
Endocrine System Diseases (6) · Hyperparathyroidism (4) · Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Musculoskeletal Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Abnormalities, Multiple (1)
Cholecalciferol (1) · Cinacalcet (1) · Fish Oils (1) · Parathyroid Hormone (1) · Standard of Care (1) · Transplantation, Autologous (1) · paricalcitol (1)
Bambino Gesù Hospital and Research Institute (1) · Chengdu Suncadia Medicine Co., Ltd. (1) · ENRICO VERRINA (1) · Medical University of Vienna (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · The Second Hospital of Anhui Medical University (1)
Austria (1) · China (1) · Holy See (1) · Italy (1) · United States (1)
Enrico E. Verrina, MD (1) · John P Bilezikian, MD (1) · Kyra Borchhardt, MD (1) · Marco Armando, MD, PhD (1)
PMID 11576947, PMID 15828905, PMID 19480654, PMID 20435429, PMID 22202993, PMID 23222688, PMID 25950238
2009 (1)